We Engage in Our Business Activities Through Multiple Subsidiary Entities
We undertake our business activities through several subsidiaries:
Lipocube specializes in the development of advanced medical devices that enable the extraction and processing of autologous adipose-based stem cells.
Recure develops, produces and markets cosmetics, supplements, and injectables featuring our proprietary Hybrid Exosomes (Hybrosomes™) technology that promote tissue regeneration and rejuvenation.
LRI provides diagnostics, treatments, and clinical services that help individuals live healthier and longer lives.
Exocube will introduce medical devices for the extraction and processing of autologous exosomes, bringing yet another dimension to regenerative medicine.
Coming Soon
